

Advances in technology are increasing the relevance of diagnostic testing, while enabling us to make it less painful and more convenient than ever.

We are proud to be the undisputed leader in a dynamic industry that provides a critical healthcare service to doctors and patients.

We drove strong organic revenue growth and increased profitability. Cash from operations reached $952 million, an increase of $100.Earnings per share grew 13% to $3.14, despite a reduction of 9% inĢ006 associated with accounting changes and special charges and.We enhanced our value proposition to patients, physicians, hospitals and payers, and we reported strong financial performance.Īmong the many highlights of our 2006 financial performance: TO OU R SH A R E HOL DE R S, EM P L OY E E S A N D CUS T OM E R S :Ģ006 was a year of outstanding performance for Quest Diagnostics.
